Aaron Foster is the founder of Sana Biotechnology. Sana Biotechnology has raised $588M in total funding. Latest round: IPO.
Aaron Foster, Ph.D., was the Vice President of T Cell Therapeutics at Sana Biotechnology, where he oversaw the development of allogeneic and in vivo gene delivery platforms and led non-clinical and IND-enabling research for T cell therapy pipeline programs. Prior to Sana, he served as Senior Vice President, Head of Research at Bellicum Pharmaceuticals, where he oversaw the company’s research strategy and led discovery and product development for CAR T and CAR NK cell therapies. He has more than 30 years of drug discovery experience.
Full founder directory · Investor directory · Company funding database · Fundraising library